Spots Global Cancer Trial Database for Observational Registry Study of Chinese Patients Treated With Revlimid (Lenalidomide)
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: Observational Registry Study of Chinese Patients Treated With Revlimid (Lenalidomide)
Official Title: A Non-interventional, Observational Post-marketing Registry of Multiple Myeloma Adult Patients Treated With Revlimid (Lenalidomide) in China
Study ID: NCT01947309
Conditions
Interventions
Study Description
Brief Summary: The primary objective of this study is to document efficacy and safety data in a real-world setting of Chinese multiple myeloma patients who have received at least one prior therapy treated with REVLIMID (lenalidomide).
Detailed Description: This registry is prospective, multi-center, observational study and will collect efficacy and safety data on multiple myeloma adult patients who have received at least one prior therapy and take REVLIMID as part of standard care associated with patients' treatment in order to characterize the use, efficacy and outcomes of REVLIMID treatment. The registry will capture data from 600 patients being prescribed REVLIMID in specified hospitals and all patients will be followed in the registry for two years after enrollment of the last patient.
Eligibility
Minimum Age: 18 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: ALL
Healthy Volunteers: No
Locations
Peking Chao-Yang Hospital, Beijing, , China
Peking University People's Hospital, Beijing, , China
People's Liberation Army Hospital 307, Beijing, , China
Beijing Hospital, Beijing, , China
The Fisrt Hospital Of Jilin University, Changchun, , China
Xiangya Hospital Central-South University, Changsha, , China
Xinqiao Hospital, 3rd Military Medical University, Chongqing, , China
NanFang Hospital of China Southern Medical University, Guangzhou, , China
The First Affliated Hospital of Anhui Medical University, Hefei, , China
Qilu Hospital of Shandong University, Jinan, , China
The Affiliated Hospital of Mecical College Qingdao University, Qingdao, , China
Shanghai Changzhen Hospital, Shanghai, , China
The Second Affiliated Hospital Of China Medical University, Shenyang, , China
The First Affiliated Hospital of Suzhou University, Suzhou, , China
People's Hospital of Xinjiang Uygur Autonomous Region, Urumqi, , China
Wuhan Union Hospital of Tongji Medical College of Huazhong University of Science & Technology, Wuhan, , China
Tongji Medical College Huazhong University of Science & Technology, Wuhan, , China
Contact Details
Name: Yu (Flora) Yao, MD
Affiliation: Celgene Pharmaceutical (Shanghai) Co. Ltd.
Role: STUDY_DIRECTOR
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
